167 related articles for article (PubMed ID: 30739527)
1. Reduced aquaporin-1 transcript expression in colorectal carcinoma is associated with promoter hypermethylation.
Smith E; Tomita Y; Palethorpe HM; Howell S; Nakhjavani M; Townsend AR; Price TJ; Young JP; Hardingham JE
Epigenetics; 2019 Feb; 14(2):158-170. PubMed ID: 30739527
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis.
Tong JD; Jiao NL; Wang YX; Zhang YW; Han F
Neoplasma; 2011; 58(5):441-8. PubMed ID: 21744999
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
[TBL] [Abstract][Full Text] [Related]
4. Receptor Tyrosine Kinase EphB3: a Prognostic Indicator in Colorectal Carcinoma.
Xuan Z; Huang J; Gao L; Wang Y; Wang J; Sun Y
Pathol Oncol Res; 2020 Jan; 26(1):541-549. PubMed ID: 30535864
[TBL] [Abstract][Full Text] [Related]
5. Aquaporin-1 promoter hypermethylation is associated with improved prognosis in salivary gland adenoid cystic carcinoma.
Tan M; Shao C; Bishop JA; Feng Z; Trock BJ; Westra WH; Ha PK
Otolaryngol Head Neck Surg; 2014 May; 150(5):801-7. PubMed ID: 24493792
[TBL] [Abstract][Full Text] [Related]
6. EphA3 Downregulation by Hypermethylation Associated with Lymph Node Metastasis and TNM Stage in Colorectal Cancer.
Wang Y; Xuan Z; Wang B; Zhang D; Zhang C; Wang J; Sun Y
Dig Dis Sci; 2019 Jun; 64(6):1514-1522. PubMed ID: 30560328
[TBL] [Abstract][Full Text] [Related]
7. Expression of aquaporin 1, 3 and 5 in colorectal carcinoma: correlation with clinicopathological characteristics and prognosis.
Zhang G; Hao Y; Chen L; Li Z; Gao L; Tian J; Qiao Q; Zhang J
Pathol Oncol Res; 2023; 29():1611179. PubMed ID: 37334171
[No Abstract] [Full Text] [Related]
8. CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer.
Cleven AH; Derks S; Draht MX; Smits KM; Melotte V; Van Neste L; Tournier B; Jooste V; Chapusot C; Weijenberg MP; Herman JG; de Bruïne AP; van Engeland M
Clin Cancer Res; 2014 Jun; 20(12):3261-71. PubMed ID: 24928946
[TBL] [Abstract][Full Text] [Related]
9. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Relevance of SFRP1 Gene Promoter Methylation in Colorectal Carcinoma.
Kumar A; Gosipatala SB; Pandey A; Singh P
Asian Pac J Cancer Prev; 2019 May; 20(5):1571-1577. PubMed ID: 31128064
[TBL] [Abstract][Full Text] [Related]
11. IGFBP3 gene promoter methylation analysis and its association with clinicopathological characteristics of colorectal carcinoma.
Kumar A; Singh P; Pandey A; Gosipatala SB
Mol Biol Rep; 2020 Sep; 47(9):6919-6927. PubMed ID: 32929656
[TBL] [Abstract][Full Text] [Related]
12. AQP1 and AQP3 Expression are Associated With Severe Symptoms and Poor-prognosis of the Pancreatic Ductal Adenocarcinoma.
Zou W; Yang Z; Li D; Liu Z; Zou Q; Yuan Y
Appl Immunohistochem Mol Morphol; 2019 Jan; 27(1):40-47. PubMed ID: 30531392
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance and potential drug target of O6-methylguanine-DNA methyltransferase in colorectal cancer: a meta-analysis.
Zheng CG; Jin C; Ye LC; Chen NZ; Chen ZJ
Tumour Biol; 2015 Aug; 36(8):5839-48. PubMed ID: 25716203
[TBL] [Abstract][Full Text] [Related]
14. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.
Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K
Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance and biological role of KLF17 as a tumour suppressor in colorectal cancer.
Jiang X; Shen TY; Lu H; Shi C; Liu Z; Qin H; Wang F
Oncol Rep; 2019 Nov; 42(5):2117-2129. PubMed ID: 31545467
[TBL] [Abstract][Full Text] [Related]
16. Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiation.
Tae CH; Ryu KJ; Kim SH; Kim HC; Chun HK; Min BH; Chang DK; Rhee PL; Kim JJ; Rhee JC; Kim YH
BMC Cancer; 2013 Mar; 13():142. PubMed ID: 23517143
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S
Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036
[TBL] [Abstract][Full Text] [Related]
18. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.
Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652
[TBL] [Abstract][Full Text] [Related]
19. Significance of PITX2 Promoter Methylation in Colorectal Carcinoma Prognosis.
Semaan A; Uhl B; Branchi V; Lingohr P; Bootz F; Kristiansen G; Kalff JC; Matthaei H; Pantelis D; Dietrich D
Clin Colorectal Cancer; 2018 Jun; 17(2):e385-e393. PubMed ID: 29580650
[TBL] [Abstract][Full Text] [Related]
20. p16INK4a gene promoter hypermethylation in mucosa as a prognostic factor for patients with colorectal cancer.
Wettergren Y; Odin E; Nilsson S; Carlsson G; Gustavsson B
Mol Med; 2008; 14(7-8):412-21. PubMed ID: 18418463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
